Wellco Brands launches pain relief cream for under the nose of cold, allergy sufferers
BUFFALO, N.Y. — Wellco Brands on Thursday launched Healerz for Noses, a pain relief cream to soothe the skin under the nose that becomes irritated during cold and allergy season.
Healerz is formulated with lidocaine for pain relief, benzalkonium chloride antiseptic to help guard against infection and aloe for its soothing properties.
Each package contains six single-use packets.
Research: Smokers who quit before 40 reduce risk of death associated with smoking by 90%
WALTHAM, Mass. — One-of-every-4 deaths among Americans between the ages of 35 years and 69 years can be attributed to smoking, according to a study published Thursday in The New England Journal of Medicine. But smoking cessation efforts can help curb that trend, researchers noted.
"Adults who had quit smoking at 25 to 34, 35 to 44, or 45 to 54 years of age gained about 10, 9, and 6 years of life, respectively, as compared with those who continued to smoke," the report noted. "Cessation before the age of 40 years reduces the risk of death associated with continued smoking by about 90%."
Researchers reviewing smoking and smoking-cessation histories from the U.S. National Health Interview Survey found that the rate of death among current smokers was about three times that among those who had never smoked. In addition, smokers on average died 10 years sooner than non-smokers on average.
Find us on Facebook for more insight, analysis and the latest in drug store news.
Industry challenges egregious disease-state related claims made by Internet purveyor of supplements
NEW YORK — The National Advertising Division on Tuesday recommended that Nature’s Answer discontinue a wide range of Internet advertising claims for “Bio-Strath,” including claims that the supplement benefits children with ADD/ADHD, pregnant women, people recovering from cancer treatments, people with dementia and people with diabetes.
Nature’s Answer agreed to comply.
Though the advertiser “submitted a variety of clinical studies testing the efficacy of Bio-Strath supplements and elixir on a variety of health parameters,” NAD noted concerns with the methodology of the studies. “Clinically proven claims are a promise that there is scientific evidence that proves or ‘establishes’ the truth of an advertiser’s claims and literally speaks to the testing of the product in terms of its claimed efficacy,” NAD noted in its decision. “There is an implied promise that the clinical testing was grounded in sound scientific methodology and yielded consumer relevant results.”
Bio-Strath is a proprietary herbal blend of angelica root, lemon balm leaf, basil aerial parts, chamomile flower, cinnamon bark, caraway seed, elder flower, fennel seed, horseradish root, hyssop leaf, lavender flower, parsley aerial parts, peppermint leaf, sage leaf and thyme aerial parts. Bio-Strath contains minerals and trace elements, amino acids, vitamins and what the advertiser describes as “building substances.” Bio-Strath also contains saccharomyces cerevisiae, commonly known as baker’s yeast, which the advertiser seems to credit for most of the rejuvenating and health properties of Bio-Strath.
NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus. As part of NAD’s initiative with the Council for Responsible Nutrition to expand NAD review of advertising claims for dietary supplements, CRN challenged certain advertising claims made by Nature’s Answer for Bio-Strath.